monoclonal antibody mab oc125 detects cell ca125 expressed NUMBER epithelial ovarian cancers normal adult ovaries high specificity binding affinity makes oc125 potential candidate use radioimmunotherapy rit patients recurrent ovarian cancer initial biodistribution studies using radiolabelled specific mabs demonstrated significant increase tumor uptake dose compared radiolabelled irrelevant antibody report isodose comparison cytotoxicity oc125 fab2 nonspecific protein external beam irradiation using gamma source enhancement cytotoxity specific binding mab observed critical activity 131i localized cell membrane specific activity labelling NUMBER antigen specificity oc125 does contribute cell kill using specific activity NUMBER relative biological effectiveness oc125 fab2 increased factor NUMBER compared xray therapy specificity mab oc125 enhance cytotoxicity radioimmunoconjugate ric factor NUMBER low value accordance previously reported theoretical calculations long range isotopes reasons rit using 131i severe limitations conclusion necessary maximize specific activity rics isotopes order maximize ratio dose delivered specifically mab versus nonspecific protein surface antigen 131i labelled 131i labelled cesium NUMBER 131i labelled external beam low let low let iodine NUMBER membrane bound free floating mci mg mci mg